Updated February 8 at 6:25pm
Biotechnology
46 results total, viewing 11 - 20
Medrobotics Corp. was named a “rising star” in the Smaller Business Association of New England Inc.’s 2015 New England Innovation Awards. more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
(Updated 3:50 and 4:49 p.m.) ProMetic Life Sciences Inc. has entered into a partnership with biotechnology company ProThera Biologics Inc. to develop and commercialize human plasma-derived inter-alpha inhibitor proteins to treat orphan diseases, which are rare diseases affecting fewer than 200,000 people. more
Brown University leaders will break ground Thursday evening on an $88 million School of Engineering building that will focus on nanoscience and bioengineering research. more
An independent analysis of promising economic clusters for Providence to nurture has identified five stars: life sciences, food processing and packaging, social enterprise, design coupled with advanced manufacturing, and education technology. more
Life sciences company CytoSolv Inc. has been acquired by Semma Therapeutics of Cambridge, Mass., according to a Slater Technology Fund press release. more
Brown University has leased its 4,000-square-foot building at 349 Eddy St. to biotechnology firm ProThera Biologics. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »